Abivax SA (ABVX) earnings
Quarterly and annual ABVX reports and results, each read against the price at its own news timestamp. Back to the ABVX overview →
4 measured ABVX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis | Press release | -3.77% | -0.17% | |
| Abivax Presents Third Quarter 2025 Financial Results | Press release | +1.48% | -1.79% | |
| Abivax Presents First Quarter 2025 Financial Results | Press release | -0.54% | +19.08% | |
| Abivax presents third quarter 2024 key financial information | Press release | +0.21% | -1.96% |
Keep exploring
More ABVX: analyst actions → · SEC filings → · ABVX overview →